Evidence map›Paper›PMID 36961727›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2023

Radiation therapy for vulvar cancer: consensus guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology. Part 1: clinical recommendations.

Sofia Cordoba Largo, Isabel Rodriguez Rodriguez, Silvia Rodriguez Villalba, Dina Najjari Jamal, Javier Anchuelo Latorre, Francisco Celada Álvarez, Sonia Garcia Cabezas, Cristina de la Fuente Alonso, Luz Couselo Paniagua, Irene Martínez Montesinos and 6 more

Erratum issuedAbstract readConsensus Statement
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Spanish Society for Radiation Oncology and Spanish Society of Medical Physicists recommendations on reirradiation in gynecological cancer: reirradiation techniques, survival outcomes, dose, and toxicity.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Guideline
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 1 country.

Sofia Cordoba LargoDepartment of Radiation Oncology, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain. sofia.cordoba@salud.madrid.org.ORCID http://orcid.org/0000-0001-7036-2160
Isabel Rodriguez RodriguezDepartment of Radiation Oncology, La Paz University Hospital, Madrid, Spain.ORCID http://orcid.org/0000-0002-4376-070X
Silvia Rodriguez VillalbaDepartment of Radiation Oncology, Clinica Benidorm Hospital, Benidorm, Alicante, Spain.ORCID http://orcid.org/0000-0002-4415-6563
Dina Najjari JamalDepartment of Radiation Oncology, Catalan Institut of Oncology, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.ORCID http://orcid.org/0000-0001-7815-2870
Javier Anchuelo LatorreDepartment of Radiation Oncology, Marqués de Valdecilla University Hospital, Santander, Spain.ORCID http://orcid.org/0000-0002-5421-9230
Francisco Celada ÁlvarezDepartment of Radiation Oncology, La Fe, University Hospital and Politécnico, Valencia, Spain.ORCID http://orcid.org/0000-0002-0708-5938
Sonia Garcia CabezasDepartment of Radiation Oncology, Reina Sofía, University Hospital, Córdoba, Spain.ORCID http://orcid.org/0000-0002-9373-9845
Cristina de la Fuente AlonsoDepartment of Radiation Oncology, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
Luz Couselo PaniaguaDepartment of Radiation Oncology, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
Irene Martínez MontesinosDepartment of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain.ORCID http://orcid.org/0000-0003-4682-8703
Elena Villafranca IturreDepartment of Radiation Oncology, University Hospital of Navarra, Pamplona, Spain.ORCID http://orcid.org/0000-0003-3515-4395
Belén Belinchón OlmedaDepartment of Radiation Oncology, La Paz University Hospital, Madrid, Spain.ORCID http://orcid.org/0000-0002-7726-2338
Dolores Farga AlbiolDepartment of Radiation Oncology, La Fe, University Hospital and Politécnico, Valencia, Spain.
Paola Andrea Navarrete SolanoDepartment of Radiation Oncology, Marqués de Valdecilla University Hospital, Santander, Spain.
María Sánchez BeldaDepartment of Radiation Oncology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.ORCID http://orcid.org/0000-0002-3630-4757
GINECOR (Spanish Gynaecological Tumors Group of SEOR)
Hospital Universitari i Politècnic La Fe · ESHospital Universitario La Paz · ESHospital Universitario Puerta de Hierro Majadahonda · ESMarqués de Valdecilla University Hospital · ESComplejo Hospitalario de Navarra · ESComplejo Hospitalario Universitario de Santiago · ESHospital Clínica Benidorm · ESHospital Clínico Universitario de Valladolid · ESHospital Universitario Reina Sofía · ESInstitut Català d'Oncologia · ESUniversidad de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe present consensus statement was developed by the GINECOR working group on behalf of the Spanish Society of Radiation Oncology (SEOR). Given the lack of prospective data on the management of vulvar carcinoma, this document provides an up-to-date review of radiotherapy treatment in vulvar cancer and a series of consensus-based recommendations from a group of experts.

methodsA two-round, online modified Delphi study was conducted to reach consensus treatment recommendations in three clinical settings: 1) adjuvant treatment, 2) locally-advanced vulvar cancer (LAVC), and 3) recurrent disease. After the first round, we comprehensively reviewed the available medical literature from peer-reviewed journals to assess and define the evidence-based treatment options. In the second round, participants were asked to indicate their level of agreement with the preliminary recommendations according to the GRADE (Grade of Recommendation, Assessment, Development, and Evaluation) criteria, as follows: strongly agree; agree; neither agree nor disagree; disagree; strongly disagree.

resultsThe main recommendations were as follows: 1) following surgical resection, adjuvant radiotherapy is recommended with the presence of adverse risk factors (primarily positive margins and lymph node involvement); 2) radiotherapy (with or without chemotherapy) should be considered in LAVC; and 3) in recurrent disease, radiotherapy should be individualised on a case-by-case basis. A high level of agreement over 80% was reached.

conclusionsIn the absence of robust clinical data, these final recommendations may help to select the optimal radiotherapy approach for this relatively rare cancer.

Indexed as

Radiation OncologyVulvar NeoplasmsFemaleHumansLymph NodesRadiotherapy, AdjuvantBrachytherapyChemoradiationRadiation therapySurgeryVulvar cancer

Identifiers

PMID36961727
OpenAlexW4360804500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.